Amin Sobh, Ph.D., on the effects of NSD2 overexpression in multiple myeloma
In an interview with OncLive, Amin Sobh, Ph.D., discussed findings on the role of NSD2 in modulating immune surveillance in multiple myeloma.
Posts tagged as
Amin Sobh
Cancer Researchers on the Rise: Amin Sobh, Ph.D.
Amin Sobh, Ph.D., studies multiple myeloma, the second most common blood cancer.
Amin Sobh, Ph.D., highlighted in AACR article
The article spotlights Amin Sobh's research advancing new therapeutic targets in multiple myeloma, with the help of AACR funding.
